A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders.
Signal transduction and targeted therapy, 7(1): 269 PMID 35953473 DOI 10.1038/s41392-022-01071-2
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.